Study of Efficacy, Safety, and Quality of Life of Pazopanib in Patients With Advanced and/or Metastatic Renal Cell Carcinoma After Prior Checkpoint Inhibitor Treatment
Clinical trial NCT03200717 · COMPLETED
Trial details
- NCT number
- NCT03200717
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-14
- Primary completion
- 2021-08-10
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.